274 related articles for article (PubMed ID: 22082548)
41. Angle between 1 and 4 min gives the most significant difference in time-intensity curves between benign disease and breast cancer: analysis of dynamic magnetic resonance imaging in 103 patients with breast lesions.
Hara M; Watanabe T; Okumura A; Kato K; Mohri N; Ishikawa M; Mizuno A; Takeyama H
Clin Imaging; 2009; 33(5):335-42. PubMed ID: 19712811
[TBL] [Abstract][Full Text] [Related]
42. [Combination of low and high resolution T1-weighted sequences for improved evaluation of morphologic criteria in dynamic contrast enhanced MRI of the breast].
Vomweg TW; Teifke A; Schreiber WG; Schmidt M; Thelen M
Rofo; 2002 Nov; 174(11):1445-9. PubMed ID: 12424673
[TBL] [Abstract][Full Text] [Related]
43. Magnetic resonance imaging of benign phyllodes tumors of the breast.
Kinoshita T; Fukutomi T; Kubochi K
Breast J; 2004; 10(3):232-6. PubMed ID: 15125750
[TBL] [Abstract][Full Text] [Related]
44. [Subtraction and dynamic MR images of breast cancer].
Murakami Y; Aoki M; Harada J
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Apr; 53(4):375-86. PubMed ID: 8493070
[TBL] [Abstract][Full Text] [Related]
45. Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma.
Leyendecker JR; Gakhal M; Elsayes KM; McDermott R; Narra VR; Brown JJ
J Comput Assist Tomogr; 2008; 32(2):178-84. PubMed ID: 18379298
[TBL] [Abstract][Full Text] [Related]
46. Contralateral lesions detected by preoperative MRI in patients with recently diagnosed breast cancer: application of MR CAD in differentiation of benign and malignant lesions.
Cho N; Kim SM; Park JS; Jang M; Kim SY; Chang JM; Moon WK
Eur J Radiol; 2012 Jul; 81(7):1520-6. PubMed ID: 21498016
[TBL] [Abstract][Full Text] [Related]
47. Observer study of a prototype clinical decision support system for breast cancer diagnosis using dynamic contrast-enhanced MRI.
Boroczky L; Simpson M; Abe H; Drysdale J
AJR Am J Roentgenol; 2013 Feb; 200(2):277-83. PubMed ID: 23345346
[TBL] [Abstract][Full Text] [Related]
48. Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions.
Williams TC; DeMartini WB; Partridge SC; Peacock S; Lehman CD
Radiology; 2007 Jul; 244(1):94-103. PubMed ID: 17507720
[TBL] [Abstract][Full Text] [Related]
49. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of malignant from benign orbital masses.
Yuan Y; Kuai XP; Chen XS; Tao XF
Eur J Radiol; 2013 Sep; 82(9):1506-11. PubMed ID: 23561057
[TBL] [Abstract][Full Text] [Related]
50. Three-phase dynamic breast magnetic resonance imaging with two-way subtraction.
Choi N; Han BK; Choe YH; Kim HS
J Comput Assist Tomogr; 2005; 29(6):834-41. PubMed ID: 16272861
[TBL] [Abstract][Full Text] [Related]
51. Differentiation between ductal carcinoma in situ and mastopathy using dynamic contrast-enhanced magnetic resonance imaging and a model of contrast enhancement.
Nishiura M; Tamaki Y; Murase K
Eur J Radiol; 2011 Dec; 80(3):740-3. PubMed ID: 21030170
[TBL] [Abstract][Full Text] [Related]
52. Medullary carcinoma of the breast: MRI findings.
Jeong SJ; Lim HS; Lee JS; Park MH; Yoon JH; Park JG; Kang HK
AJR Am J Roentgenol; 2012 May; 198(5):W482-7. PubMed ID: 22528930
[TBL] [Abstract][Full Text] [Related]
53. Should breast MRI be performed with adjustment for the phase in patients' menstrual cycle? Correlation between mammographic density, age, and background enhancement on breast MRI without adjusting for the phase in patients' menstrual cycle.
Uematsu T; Kasami M; Watanabe J
Eur J Radiol; 2012 Jul; 81(7):1539-42. PubMed ID: 21592704
[TBL] [Abstract][Full Text] [Related]
54. Characterization of the enhancing lesions on dynamic contrast enhanced magnetic resonance imaging in patients with interstitial mammoplasty.
Kim TY; Kim SH; Kang BJ; Kim HS; Cha ES; Kim JY; Song BJ
Eur J Radiol; 2013 Dec; 82(12):2205-11. PubMed ID: 24103354
[TBL] [Abstract][Full Text] [Related]
55. Prostate cancer: comparison of dynamic contrast-enhanced MRI techniques for localization of peripheral zone tumor.
Rosenkrantz AB; Sabach A; Babb JS; Matza BW; Taneja SS; Deng FM
AJR Am J Roentgenol; 2013 Sep; 201(3):W471-8. PubMed ID: 23971479
[TBL] [Abstract][Full Text] [Related]
56. Primary breast abnormalities: selective pixel sampling on dynamic gadolinium-enhanced MR images.
Mussurakis S; Gibbs P; Horsman A
Radiology; 1998 Feb; 206(2):465-73. PubMed ID: 9457201
[TBL] [Abstract][Full Text] [Related]
57. Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity.
Horsthuis K; Lavini C; Bipat S; Stokkers PC; Stoker J
Radiology; 2009 May; 251(2):380-7. PubMed ID: 19401571
[TBL] [Abstract][Full Text] [Related]
58. Optimizing MRI scan time in the computation of pharmacokinetic parameters (K(trans) ) in breast cancer diagnosis.
Jena A; Mehta SB; Taneja S
J Magn Reson Imaging; 2013 Sep; 38(3):573-9. PubMed ID: 23349046
[TBL] [Abstract][Full Text] [Related]
59. Comparison of gadoteric acid and gadobutrol for detection as well as morphologic and dynamic characterization of lesions on breast dynamic contrast-enhanced magnetic resonance imaging.
Renz DM; Durmus T; Böttcher J; Taupitz M; Diekmann F; Huppertz A; Pfeil A; Maurer MH; Streitparth F; Bick U; Hamm B; Fallenberg EM
Invest Radiol; 2014 Jul; 49(7):474-84. PubMed ID: 24637587
[TBL] [Abstract][Full Text] [Related]
60. Region of interest and pixel-by-pixel analysis of dynamic contrast enhanced magnetic resonance imaging parameters and time-intensity curve shapes: a comparison in chondroid tumors.
Lavini C; Pikaart BP; de Jonge MC; Schaap GR; Maas M
Magn Reson Imaging; 2009 Jan; 27(1):62-8. PubMed ID: 18619754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
